Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1997 | 03-1996 | 03-1995 | 03-1994 | 03-1993 | |
| Sales | 56,528 | 49,561 | 42,128 | 29,325 | 0 |
| Cost of Goods | N/A | N/A | 17,107 | 13,488 | N/A |
| Gross Profit | 56,528 | 49,561 | 25,021 | 15,837 | N/A |
| Operating Expenses | 0 | 0 | 19,440 | 15,923 | 0 |
| Operating Income | 56,528 | 49,561 | 5,688 | 402 | N/A |
| Other Income | 0 | 0 | 174 | 377 | 0 |
| Pre-tax Income | 56,528 | 49,561 | 5,862 | 779 | 0 |
| Income Tax | N/A | N/A | 2,454 | 830 | N/A |
| Net Income Continuous | 2,196 | 2,025 | 3,375 | 178 | 394 |
| Net Income | $2,196 | $2,025 | $3,375 | $178 | $394 |
| EPS Basic Total Ops | 0.11 | 0.10 | 0.17 | 0.01 | N/A |
| EPS Basic Continuous Ops | 0.11 | 0.10 | 0.17 | 0.01 | N/A |
| EPS Diluted Total Ops | 0.11 | 0.10 | 0.17 | 0.01 | N/A |
| EPS Diluted Continuous Ops | 0.11 | 0.10 | 0.17 | 0.01 | N/A |
| EBITDA(a) | $56,528 | $49,561 | $5,688 | $402 | $N/A |